Keyphrases
Myeloid-derived Suppressor Cells
100%
Multiple Sclerosis Treatment
100%
MiR-223
100%
Suppressive Activity
100%
Healthy Controls
44%
Multiple Sclerosis
33%
Healthy People
22%
Dysregulated
11%
Therapeutic Target
11%
Adaptive Immune Response
11%
Myeloid Cells
11%
Cell Activity
11%
T Cells
11%
In Vitro Activity
11%
Granulocyte Colony-stimulating Factor (G-CSF)
11%
Drug Target
11%
Chronic Inflammation
11%
CD4+ T Cells
11%
Chemokines
11%
In Vitro Assay
11%
Demyelinating Diseases
11%
Disease Course
11%
Multiple Linear Regression Analysis
11%
Innate Immunity
11%
Autoimmune
11%
Anti-neuroinflammation
11%
Through Effect
11%
Cell Expansion
11%
Cell Maturation
11%
Immunosuppressive Function
11%
Phosphorylated STAT3
11%
Suppressive Function
11%
Central Nervous System Demyelinating Diseases
11%
Luminex Assay
11%
Immunosuppressive Activity
11%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
100%
microRNA 223
100%
Glucocorticoid
75%
Immunosuppressive Agent
50%
Cytokine
25%
Granulocyte Macrophage Colony Stimulating Factor
25%
Disease Course
25%
Chronic Inflammation
25%
Drug Delivery System
25%
Demyelinating Disease
25%
Chemokine
25%
Diseases
25%
Immunology and Microbiology
Myeloid-Derived Suppressor Cell
100%
Multiple Sclerosis
100%
STAT3
33%
Glucocorticoid
33%
Immunosuppressive Drug
22%
Cytokine
11%
T Cell
11%
T-Helper Cell
11%
Cell Activity
11%
Immunocompetent Cell
11%
Cell Expansion
11%
Myeloid
11%
Cell Maturation
11%
Chemokine
11%
Granulocyte Macrophage Colony-Stimulating Factor
11%
Central Nervous System
11%
Innate Immune System
11%
Clinically Isolated Syndrome
11%
Drug Targeting
11%